Resolution Therapeutics
Pioneering Regenerative Macrophage Therapy in Inflammatory and Fibrotic Diseases.
Clinical stage company with lead asset in Ph1/2 in end-stage liver disease, with clinical PoC in compensated cirrhosis.
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
